News Conference News AHA 2023 Seeing Sticker Price for HFrEF Meds Opens Door to Discussions Caitlin E. Cox November 14, 2023
News Conference News AHA 2023 DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI Shelley Wood November 11, 2023
News Conference News HFSA 2023 STRONG-HF Analysis: Safety Events Common but Manageable in GDMT Optimization L.A. McKeown October 18, 2023
News Daily News Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry Michael O'Riordan September 27, 2023
News Daily News Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All Michael O'Riordan September 18, 2023
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023
News ESC 2023 Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST Michael O'Riordan August 27, 2023
News Conference News ESC 2023 IV Iron in HF Misses (Again) in HEART-FID, but Meta-analysis Sees a Role Shelley Wood August 26, 2023
News Conference News ESC 2023 STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function Shelley Wood August 25, 2023
News Daily News PCI Doesn’t Cut Arrhythmias in Severe LV Dysfunction: REVIVED-BCIS2 Analysis Todd Neale August 14, 2023
News Daily News Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF Todd Neale July 03, 2023
News Daily News Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes Michael O'Riordan June 23, 2023
News Conference News ESC Heart Failure 2023 SGLT2i Still Underprescribed in HFrEF, New US Analysis Confirms L.A. McKeown June 06, 2023
News Conference News ESC Heart Failure 2023 Boosting GDMT and Improving Outcomes? No Mean Task After AHF Shelley Wood June 01, 2023